Clicky

Surmodics Inc(SU6)

Description: Surmodics, Inc., together with its subsidiaries, provides performance coating technologies for intravascular medical devices, and chemical and biological components for in vitro diagnostic immunoassay tests and microarrays in the United States and internationally. It operates through two segments, Medical Device and In Vitro Diagnostics (IVD). The Medical Device segment engages in the provision of surface modification coating technologies to enhance access, deliverability, and predictable deployment of medical devices; and drug-delivery coating technologies to provide site-specific drug-delivery from the surface of a medical device for neurovascular, peripheral, coronary, and structural heart, and other markets, as well as manufacturing of vascular intervention medical devices, including drug-coated balloons, mechanical thrombectomy devices, and radial access balloon catheters and guide sheaths. The IVD segment develops, manufactures, and sells chemical and biological components for in vitro diagnostic immunoassay and molecular tests, as well as diagnostic and biomedical research markets. This segment offers protein stabilizers, substrates, surface coatings, and antigens. The company was founded in 1979 and is headquartered in Eden Prairie, Minnesota.


Keywords: Chemical Health Care Medical Device Catheter Drug Delivery Medical Test Immunoassay In Vitro Diagnostics Ivd Drug Delivery Coating Technologies Surface Modification Coating Technologies

Home Page: www.surmodics.com

9924 West 74th Street
Eden Prairie, MN 55344-3523
United States
Phone: 952 500 7000


Officers

Name Title
Mr. Gary R. Maharaj CEO, President & Director
Mr. Timothy J. Arens Senior VP of Finance & Information Technology and CFO
Mr. Gordon S. Weber J.D. Senior VP of Legal, General Counsel & Secretary
Mr. Charles W. Olson Senior VP & President of Medical Device Coatings
Ms. Teryl L. W. Sides Senior VP & President of Vascular Interventions
Mr. John D. Manders Corporate Controller, VP of Finance & Principal Accounting Officer
Joel Suiter Director of Corporate Development
Mr. Joseph J. Stich Senior VP of Human Resources & President of In Vitro Diagnostics

Exchange: F

Country: DE : Germany

Currency: Euro (€)

Forward PE: 43.8596
Trailing PE: 0
Price-to-Book MRQ: 4.6936
Price-to-Sales TTM: 4.3162
IPO Date:
Fiscal Year End: September
Full Time Employees: 0
Back to stocks